期刊文献+

乳腺癌缺失基因1在子宫内膜癌中的表达及意义 被引量:3

原文传递
导出
摘要 目的检测乳腺癌缺失基因1(deletedinbreastcancer1,DBCl)在子宫内膜腺癌组织中的表达情况,探讨其在肿瘤发展过程中的作用。方法收集山东省聊城市人民医院28例子宫内膜腺癌患者手术切除的新鲜子宫内膜癌组织及癌旁正常子宫内膜组织,所有患者术前均未应用放疗、化疗等治疗,采用荧光定量PCR和Western免疫印迹技术检测DBC1在子宫内膜腺癌组织及其癌旁正常子宫内膜组织中的表达情况。结果荧光定量PCR结果显示子宫内膜腺癌组织中DBC1 mRNA的表达量与癌旁正常组织相比,其相对表达量为3.05,二者比较差异有统计学意义(P〈0.05);Western免疫印迹结果显示子宫内膜癌组织及癌旁正常组织中DBC1蛋白质的表达与内参基因B-actin相比,二者的相对表达量分别为1.01±0.08;0.66±0.14,二者比较差异有统计学意义(P〈0.05)。结论DBC1在子宫内膜腺癌中过表达,可能在疾病发展过程中作为促癌基因发挥作用。
出处 《中国综合临床》 2015年第1期78-80,共3页 Clinical Medicine of China
  • 相关文献

参考文献12

  • 1陶春英,张婷,杨晓娟,李云芬,聂建云.DBC1的研究进展[J].现代肿瘤医学,2013,21(7):1653-1655. 被引量:4
  • 2Kim JE,Sung S.Deleted in breast cancer 1(DBC1)is adynamically regulated protein[J].Neoplasma,2010,57(4):365-368.
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013[J].CACancer J Clin,2013,63(1):11-30.
  • 4Chini EN,Chini CC,Nin V,et al.Deleted in breast cancer-1(DBC-1)in the interface between metabolism,aging and cancer[J].Biosci Rep,2013,33(4):637-643.
  • 5Song NY,Surh YJ.Janus-faced role of SIRT1 in tumorigenesis[J].Ann N Y Acad Sci,2012,1271:1049.
  • 6李云芬,杨晓娟,张婷,陶春英,聂建云.乳腺癌组织中乳腺癌缺失基因1的表达研究进展[J].现代肿瘤医学,2013,21(8):1888-1891. 被引量:5
  • 7Zhang Y,Gu Y,Sha S,et.al.DBC1 is over-expressed andassociated with poor prognosis in colorectal cancer[J].Int J Clin Oncol,2014,19(1):106-112.
  • 8Bae HJ,Chang YG,Noh JH,et al.DBC1 does not function as a negative regulator of SIRT1 in liver cancer[J].Oncol Lett,2012,4(5):873-877.
  • 9Kang Y,Jung WY,Lee H,et al.Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma[J].Korean J Pathol,2012,46(6):523-531.
  • 10Yu XM,Liu Y,Jin T,et al.The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas[J].PLoS One,2013,8(6):e66975.

二级参考文献52

  • 1范颖,沙立春,李斌,刘鹏博(编校).雌激素受体亚型与雌激素依赖性妇科疾病的关系[J].中国妇幼保健,2007,22(7):970-973. 被引量:22
  • 2Dobrzycka B, Terlikowski S J, Garbowicz M. The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer [J]. Folia Histochem Cytobiol,2011, 49(4) :631-635,.
  • 3Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond [J]. Biochim Biophys Acta,2010,1804 ( 8 ) : 1684-1689.
  • 4Tavassoli FA, Devilee P. World Health Organization: Tumours of the breast and female genital organs [M]. 3rd ed. Lyon: IARC Press-WHO ,2003:221-227.
  • 5Maiese K, Chong ZZ, Shang YC, et al. Translating cell survival and cell longevity into treatment strategies with SIRT1. [J]. Rom J Morphol Embryol,2011,52 (4) : 1173-1185.
  • 6Inoue Y,Iemura S, Natsume T, et al. Suppression of p53 activity through the cooperative action of Ski and histone deaeetylase SIRT1 [J]. J Biol Chem,2011,286(8) :6311-6320.
  • 7Audrito V, Vaisitti T, Rossi D, et al. Nieotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network [ J]. Cancer Res ,2011,71 (13) :4473-4483.
  • 8Shah ZH, Ahmed SU, Ford JR, et al. A deacetylase-deficient SIRT1 variant opposes fuU-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genes [J]. Mol Cell Biol,2012,32(3) :704-716.
  • 9Jemal A,Siegel R, Ward E, et al. Cancer statistics,2009 [J]. CA Cancer J Clin,2009,59(4) :225-249.
  • 10周力恒,殷文瑾,陆劲松,狄根红,吴炅,沈坤炜,韩企夏,沈镇宙,邵志敏.雌激素受体阳性孕激素受体表达不同的乳腺癌患者肿瘤特征比较[J].中华医学杂志,2007,87(39):2764-2767. 被引量:14

共引文献5

同被引文献23

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部